Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1271-1279
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1271
Table 1 Baseline data between the two groups of patients

R-TME (n = 45)
L-TME (n = 50)
t/Z/χ2 value
P value
Age [yr, Md (IQR)]68 (64, 71)69 (65, 75)-1.76310.078
Gender, n (%)0.6820.409
Male26 (57.7)33 (66.0)
Female19 (42.3)17 (34.0)
BMI (kg/m2, mean ± SD)23.43 ± 2.5223.85 ± 3.02-0.7330.467
Tumor level from anal verge (cm), n (%)0.81820.664
    5-1025 (55.6)24 (48.0)
    11-1514 (31.1)20 (40.0)
    > 156 (13.3)6 (12.0)
History of cardiopulmonary disease, n (%)0.06820.794
    Yes21 (46.7)22 (44.0)
    No24 (53.3)28 (56.0)
HGB (g/L, mean ± SD)125.22 ± 12.31127.22 ± 17.86-0.62830.532
ALB (g/L, mean ± SD)39.82 ± 2.7739.19 ± 3.181.0230.31
History of abdominal surgery, n (%)3.21420.073
    Yes9 (20.0)17 (34.0)
    No36 (80.0)33 (66.0)
History of neoadjuvant therapy, n (%)0.25320.615
    Yes7 (15.6)6 (12.0)
    No38 (84.4)44 (88.0)
    ASA level, n (%)1.13320.287
    II30 (66.7)28 (56.0)
    III15 (33.3)22 (44.0)